Pharmaceuticals, Biotechnology and Life Sciences
– Clinical efficacy continued to deepen over time with three SLE patients in DORIS remission, the first LN patient achieving…
LOUISVILLE, Ky., Feb. 17, 2025 (GLOBE NEWSWIRE) — Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a…
Mechelen, Belgium; February 17, 2025, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification…
IRVINE, Calif., Feb. 17, 2025 (GLOBE NEWSWIRE) — Targeted Genomics LLC, a family owned genetic testing Company, today announced receipt…
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions…
WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) — Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.”…
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for…
Moderna reports full-year revenues of $3.2 billion, GAAP net loss of $(3.6) billion and GAAP diluted EPS of $(9.28), and expects 2025 revenue range of $1.5 to 2.5 billion andending cash balance of approximately $6 billion.
JENA, Germany, Feb. 13, 2025 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics…
MONTREAL, Feb. 13, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a specialty biopharmaceutical…